Related Experiment Videos
Lamotrigine in the treatment of SUNCT syndrome
G D'Andrea1, F Granella, N Ghiotto
1Headache and Comorbidity Center, Pathology Unit, Este-Monselice Hospital, Este, Italy.
Neurology
|November 14, 2001
Abstract:
Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is considered an intractable condition. The authors treated five patients with lamotrigine (125 to 200 mg daily), obtaining a complete remission in three patients and a substantial reduction (about 80%) of attack frequency in the other two. No adverse effects were noted.